KKR has agreed to acquire Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company. CEO Dr. Urs Spitz and senior managers will remain significant owners, ...

Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets LONDON--(BUSINESS WIRE)-- KKR, a leading global ...

Biosynth Carbosynth, which is backed by KKR, has acquired vivitide, a provider of custom peptides and antibodies for the life sciences and biotech industry. Existing vivitide owner Ampersand Capital ...

Rebranding aligns core Biosynth Group members across Complex Chemical and Peptide Manufacturing Services and Catalog Business. STAAD, Switzerland--(BUSINESS WIRE)--Biosynth Carbosynth, vivitide and ...

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today the acquisition of Aalto Bio Reagents (“Aalto”), a ...

Biosynth Carbosynth (“Biosynth”) announces today that it has signed an agreement to acquire EUCODIS Bioscience (“EUCODIS”). The two companies have worked together on innovation projects in enzyme ...

Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition of Pepscan, an expert provider of peptide-based products & ...

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group and the launch of their site at ...

Addition of Aalto Bio Reagents expands Biosynth Carbosynth’s offer to its clinical diagnostics customers. STAAD, Switzerland, May 26, 2022--(BUSINESS WIRE)--Biosynth Carbosynth ("Biosynth"), a ...